224 related articles for article (PubMed ID: 1670896)
1. c-myc reverses neu-induced transformed morphology by transcriptional repression.
Suen TC; Hung MC
Mol Cell Biol; 1991 Jan; 11(1):354-62. PubMed ID: 1670896
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of either c-myc or c-erbB-2/neu proto-oncogenes in human breast carcinomas: correlation with poor prognosis.
Guérin M; Barrois M; Terrier MJ; Spielmann M; Riou G
Oncogene Res; 1988; 3(1):21-31. PubMed ID: 2905033
[TBL] [Abstract][Full Text] [Related]
3. neu and ras initiate murine mammary tumors that share genetic markers generally absent in c-myc and int-2-initiated tumors.
Morrison BW; Leder P
Oncogene; 1994 Dec; 9(12):3417-26. PubMed ID: 7970700
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional repression of the neu protooncogene by the adenovirus 5 E1A gene products.
Yu D; Suen TC; Yan DH; Chang LS; Hung MC
Proc Natl Acad Sci U S A; 1990 Jun; 87(12):4499-503. PubMed ID: 1972274
[TBL] [Abstract][Full Text] [Related]
5. Characterization of a repressor element and a juxtaposed tissue-restricted activator element located on the distal neu gene promoter.
Suen TC; Goss PE
J Biol Chem; 2000 Mar; 275(9):6600-7. PubMed ID: 10692468
[TBL] [Abstract][Full Text] [Related]
6. Negative autoregulation of the neu gene is mediated by a novel enhancer.
Zhao XY; Hung MC
Mol Cell Biol; 1992 Jun; 12(6):2739-48. PubMed ID: 1350324
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of c-erbB2/neu oncogene-induced metastasis and repression of metastatic properties by adenovirus 5 E1A gene products.
Yu D; Hamada J; Zhang H; Nicolson GL; Hung MC
Oncogene; 1992 Nov; 7(11):2263-70. PubMed ID: 1359495
[TBL] [Abstract][Full Text] [Related]
8. Oncogenic Neu/ErbB-2 increases ets, AP-1, and NF-kappaB-dependent gene expression, and inhibiting ets activation blocks Neu-mediated cellular transformation.
Galang CK; García-Ramírez J; Solski PA; Westwick JK; Der CJ; Neznanov NN; Oshima RG; Hauser CA
J Biol Chem; 1996 Apr; 271(14):7992-8. PubMed ID: 8626480
[TBL] [Abstract][Full Text] [Related]
9. Evidence for a cancer-specific switch at the CDK4 promoter with loss of control by both USF and c-Myc.
Pawar SA; Szentirmay MN; Hermeking H; Sawadogo M
Oncogene; 2004 Aug; 23(36):6125-35. PubMed ID: 15208653
[TBL] [Abstract][Full Text] [Related]
10. Acquisition of a tumorigenic phenotype by a rat ventral prostate epithelial cell line expressing a transfected activated neu oncogene.
Sikes RA; Chung LW
Cancer Res; 1992 Jun; 52(11):3174-81. PubMed ID: 1350510
[TBL] [Abstract][Full Text] [Related]
11. The role of non-ras transforming genes in chemical carcinogenesis.
Cooper CS
Environ Health Perspect; 1991 Jun; 93():33-40. PubMed ID: 1685444
[TBL] [Abstract][Full Text] [Related]
12. Amplification of the proto-neu oncogene facilitates oncogenic activation by a single point mutation.
Hung MC; Yan DH; Zhao XY
Proc Natl Acad Sci U S A; 1989 Apr; 86(8):2545-8. PubMed ID: 2565034
[TBL] [Abstract][Full Text] [Related]
13. The retinoblastoma gene product suppresses neu oncogene-induced transformation via transcriptional repression of neu.
Yu D; Matin A; Hung MC
J Biol Chem; 1992 May; 267(15):10203-6. PubMed ID: 1350277
[TBL] [Abstract][Full Text] [Related]
14. A global transcriptional regulatory role for c-Myc in Burkitt's lymphoma cells.
Li Z; Van Calcar S; Qu C; Cavenee WK; Zhang MQ; Ren B
Proc Natl Acad Sci U S A; 2003 Jul; 100(14):8164-9. PubMed ID: 12808131
[TBL] [Abstract][Full Text] [Related]
15. Aberrant expression of the c-erbB-2/neu protooncogene in ovarian cancer.
Hung MC; Zhang X; Yan DH; Zhang HZ; He GP; Zhang TQ; Shi DR
Cancer Lett; 1992 Jan; 61(2):95-103. PubMed ID: 1346099
[TBL] [Abstract][Full Text] [Related]
16. Transformation of NIH 3T3 cells by overexpression of the normal coding sequence of the rat neu gene.
Di Marco E; Pierce JH; Knicley CL; Di Fiore PP
Mol Cell Biol; 1990 Jun; 10(6):3247-52. PubMed ID: 1971420
[TBL] [Abstract][Full Text] [Related]
17. Evidence that Myc isoforms transcriptionally repress caveolin-1 gene expression via an INR-dependent mechanism.
Park DS; Razani B; Lasorella A; Schreiber-Agus N; Pestell RG; Iavarone A; Lisanti MP
Biochemistry; 2001 Mar; 40(11):3354-62. PubMed ID: 11258956
[TBL] [Abstract][Full Text] [Related]
18. Strategies for the analysis of oncogene overexpression. Studies of the neu oncogene in breast carcinoma.
Naber SP; Tsutsumi Y; Yin S; Zolnay SA; Mobtaker H; Marks PJ; McKenzie SJ; DeLellis RA; Wolfe HJ
Am J Clin Pathol; 1990 Aug; 94(2):125-36. PubMed ID: 1973590
[TBL] [Abstract][Full Text] [Related]
19. Repression of transcription of the p27(Kip1) cyclin-dependent kinase inhibitor gene by c-Myc.
Yang W; Shen J; Wu M; Arsura M; FitzGerald M; Suldan Z; Kim DW; Hofmann CS; Pianetti S; Romieu-Mourez R; Freedman LP; Sonenshein GE
Oncogene; 2001 Mar; 20(14):1688-702. PubMed ID: 11313917
[TBL] [Abstract][Full Text] [Related]
20. Negative regulation of the neu promoter by the SV40 large T antigen.
Matin A; Hung MC
Cell Growth Differ; 1993 Dec; 4(12):1051-6. PubMed ID: 7906953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
